Venus Remedies Limited (VENUSREM.BO)
INR 325.25
(-0.15%)
INR 325.25
(-0.15%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.21 Billion INR | 1.46% |
| 2022 | 1.19 Billion INR | -4.54% |
| 2021 | 1.25 Billion INR | 4.71% |
| 2020 | 1.19 Billion INR | -14.98% |
| 2019 | 1.41 Billion INR | -1.12% |
| 2018 | 1.42 Billion INR | 3.29% |
| 2017 | 1.38 Billion INR | -1.72% |
| 2016 | 1.4 Billion INR | -1.88% |
| 2015 | 1.43 Billion INR | 0.3% |
| 2014 | 1.42 Billion INR | 0.43% |
| 2013 | 1.42 Billion INR | 11.11% |
| 2012 | 1.28 Billion INR | 32.24% |
| 2011 | 968.15 Million INR | 28.35% |
| 2010 | 754.29 Million INR | 21.78% |
| 2009 | 619.41 Million INR | 38.96% |
| 2008 | 445.76 Million INR | 60.49% |
| 2007 | 277.75 Million INR | 53.66% |
| 2006 | 180.76 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.2 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.59 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 1.21 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.21 Billion INR | 1.46% |
| 2022 Q2 | 1.46 Billion INR | 0.0% |
| 2022 FY | 1.19 Billion INR | -4.54% |
| 2022 Q4 | 1.19 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.25 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.33 Billion INR | 0.0% |
| 2021 FY | 1.25 Billion INR | 4.71% |
| 2020 FY | 1.19 Billion INR | -14.98% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 1.27 Billion INR | 0.0% |
| 2020 Q4 | 1.19 Billion INR | 0.0% |
| 2019 Q4 | 1.41 Billion INR | 0.0% |
| 2019 FY | 1.41 Billion INR | -1.12% |
| 2019 Q2 | 1.44 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 FY | 1.42 Billion INR | 3.29% |
| 2018 Q4 | 1.42 Billion INR | 0.0% |
| 2017 FY | 1.38 Billion INR | -1.72% |
| 2016 FY | 1.4 Billion INR | -1.88% |
| 2016 Q4 | 1.4 Billion INR | 0.0% |
| 2015 FY | 1.43 Billion INR | 0.3% |
| 2014 FY | 1.42 Billion INR | 0.43% |
| 2013 Q4 | 1.42 Billion INR | 0.0% |
| 2013 FY | 1.42 Billion INR | 11.11% |
| 2012 Q4 | 1.28 Billion INR | 0.0% |
| 2012 Q2 | 216.17 Million INR | 0.0% |
| 2012 FY | 1.28 Billion INR | 32.24% |
| 2011 FY | 968.15 Million INR | 28.35% |
| 2010 FY | 754.29 Million INR | 21.78% |
| 2009 FY | 619.41 Million INR | 38.96% |
| 2008 FY | 445.76 Million INR | 60.49% |
| 2007 FY | 277.75 Million INR | 53.66% |
| 2006 FY | 180.76 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 85.31% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -321.004% |
| Sigachi Industries Limited | 707.2 Million INR | -72.071% |
| Bal Pharma Limited | 878.11 Million INR | -38.581% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -1063.64% |
| Medico Remedies Limited | 163.37 Million INR | -644.864% |
| Lasa Supergenerics Limited | 190.43 Million INR | -539.014% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -790.504% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 82.84% |
| Shilpa Medicare Limited | 3.44 Billion INR | 64.72% |
| Aarti Drugs Limited | 4.85 Billion INR | 74.955% |
| Lupin Limited | 49.53 Billion INR | 97.544% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 98.759% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 96.464% |
| Windlas Biotech Limited | 621.89 Million INR | -95.678% |
| Suven Life Sciences Limited | 7.08 Million INR | -17075.723% |
| Eris Lifesciences Limited | 1.89 Billion INR | 35.625% |
| Valiant Laboratories Limited | 100.15 Million INR | -1115.029% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 75.784% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 66.169% |
| Ipca Laboratories Limited | 24.71 Billion INR | 95.076% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -2.738% |
| Achyut Healthcare Limited | 568 Thousand INR | -214142.958% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 98.767% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 15.515% |
| RPG Life Sciences Limited | 1.01 Billion INR | -20.485% |
| Mankind Pharma Limited | 15.53 Billion INR | 92.167% |
| Laurus Labs Limited | 18.45 Billion INR | 93.406% |
| Piramal Pharma Limited | 21.75 Billion INR | 94.407% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -477.236% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 94.66% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 92.596% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 95.158% |
| Unichem Laboratories Limited | 7.04 Billion INR | 82.731% |
| Sequent Scientific Limited | 3.46 Billion INR | 64.853% |
| Novartis India Limited | 448.6 Million INR | -171.266% |
| Wanbury Limited | 360.23 Million INR | -237.81% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 47.365% |
| Wockhardt Limited | 6.4 Billion INR | 80.986% |
| Themis Medicare Limited | 705.74 Million INR | -72.428% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -711.429% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 90.564% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 81.744% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.085% |
| Divi's Laboratories Limited | 31.84 Billion INR | 96.178% |
| NATCO Pharma Limited | 7 Billion INR | 82.628% |
| Gufic Biosciences Limited | 2 Billion INR | 39.301% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 71.356% |
| Ind-Swift Limited | 640.91 Million INR | -89.869% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -11.53% |
| FDC Limited | 3.88 Billion INR | 68.708% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1142.191% |
| Granules India Limited | 13 Billion INR | 90.643% |
| Medicamen Biotech Limited | 593.75 Million INR | -104.951% |
| Alkem Laboratories Limited | 26.61 Billion INR | 95.427% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 46.6% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -4672.718% |
| Brooks Laboratories Limited | 96.1 Million INR | -1166.18% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -49.749% |
| Strides Pharma Science Limited | 11.26 Billion INR | 89.195% |
| Neuland Laboratories Limited | 3.5 Billion INR | 65.273% |
| Morepen Laboratories Limited | 2.48 Billion INR | 51.049% |
| Hikal Limited | 3.03 Billion INR | 59.933% |
| Indoco Remedies Limited | 3.53 Billion INR | 65.533% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 81.071% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -2951.404% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 1.577% |
| Hester Biosciences Limited | 755.81 Million INR | -61.006% |